Tranzyme Skids After Failure of TZP-102 Study

Published November 15, 2012

Tranzyme skids after failure of TZP-102 study

Filed under: drug treatment programs in nyc

NEW YORK (AP) — Shares of Tranzyme Inc. plunged about 75 percent Thursday after the company said its diabetic gastroparesis treatment TZP-102 failed in a mid-stage clinical trial. Tranzyme said that when patients took the drug once per day, it did not …
Read more on Businessweek

Monday's Sports Transactions

Filed under: drug treatment programs in nyc

COMMISSIONER'S OFFICE_Suspended free agent RHP Rafael Martinez 50 games for violating the Minor League Drug Prevention and Treatment Program. … professional scout. NEW YORK METS_Named Jim Malone strength and conditioning coordinator.
Read more on WOOD-TV

EU okays Bristol-Astra diabetes drug after US rejection

Filed under: drug treatment programs in nyc

NEW YORK (Reuters) – European regulators have approved the first in a new class of diabetes medicines that work independently of insulin to control blood sugar, the drug's developers Bristol-Myers Squibb Co and AstraZeneca Plc said on Wednesday. The …
Read more on Reuters